InsiderClue
Insiders · Profile

Ignelzi Troy A.

Chief Financial Officer at Rapport Therapeutics. Filing since 12 Mar 2025. CIK 0001579829

Company
Date
Role
Action
Shares
Amount
Of holding
RAPP Rapport Therapeutics, Inc.
13 Mar 2025
Chief Financial Officer
Bought
100
$998.00
1.0%
RAPP Rapport Therapeutics, Inc.
12 Mar 2025
Chief Financial Officer
Bought
9,900
$99.99K
opened
2 decisions on file.